A Canadian cannabis pharmaceutical stock has signed a licensing agreement with Remidose Aerosols to acquire exclusive global rights to its metered dose inhaler and sublingual spray products, which diversify the company’s assets and will imminently enhance revenue.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Top Story: Top medical cannabis company scores sixth consecutive quarter of positive adjusted EBITDA
2 | Broken Coast medical cannabis brand launches in Australia
3 | Canadian biopharmaceutical company issued a patent for self-emulsifying drug delivery system technology
Top Cannabis Stocks June 14 to June 20, 2023
1. T.TLRY | 7,656 views | .Tilray Brands Inc.
2. T.WEED | 5,274 views | Canopy Growth Corp
3. T.LABS | 4,464 views | Medipharm Labs Corp.
4. C.OILS | 2,374 views | Nextleaf Solutions Ltd.
5. C.CURA | 2,236 views | Curaleaf Holdings Inc.
6. TSX:DN | 1,121 views | Delta 9 Cannabis Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.